According to a new report, published by KBV research, The Global Amniocentesis Needle Market size is expected to reach $283.8 million by 2030, rising at a market growth of 6.7% CAGR during the forecast period.
The market is a sector operating within the medical devices industry, which is dedicated to the manufacturing, distribution, and commercialization of needles utilized in amniocentesis procedures. Amniocentesis is a prenatal diagnostic procedure in which a needle is inserted through the pregnant woman's abdominal wall and into the amniotic sac surrounding the fetus. The catheter extracts a minute quantity of amniotic fluid containing embryonic cells and DNA. This fluid is then analyzed to assess the genetic health of the fetus, detect chromosomal abnormalities, and identify genetic disorders.
These needles, designed with precision and safety in mind, play a pivotal role in facilitating the extraction of amniotic fluid while minimizing patient discomfort and procedural risks. These specialized needles come in various sizes, configurations, and materials, offering healthcare professionals flexibility and adaptability to perform amniocentesis procedures across diverse patient populations and clinical settings. The market stakeholders include medical device manufacturers, healthcare facilities, obstetricians, perinatologists, genetic counselors, and expectant parents. Together, they form a dynamic ecosystem that delivers high-quality prenatal care, accurate genetic testing, and informed decision-making throughout pregnancy.
The Amniocentesis Procedures segment is registering a CAGR of 5.9 % during the forecast period. With more women delaying childbirth until later in life, there is a higher incidence of chromosomal abnormalities and genetic disorders associated with advanced maternal age. As a result, pregnant individuals, particularly those over the age of 35, are opting for amniocentesis procedures to assess fetal health and detect potential genetic abnormalities early in pregnancy.
The Hospitals segment led the Global Amniocentesis Needle Market, by End-use in 2022; thereby, achieving a market value of $118 million by 2030. Hospitals are central hubs for prenatal care and diagnostic procedures, including amniocentesis. Pregnant individuals often seek care from hospitals for comprehensive prenatal screening and testing, making hospitals key providers of amniocentesis procedures and associated needle products. Furthermore, hospitals often have access to advanced diagnostic technologies and equipment for performing amniocentesis.
The 100 to 150 mm is growing at a CAGR of 6.3 % during the forecast period. Patients undergoing amniocentesis come from diverse demographic backgrounds and may have varying anatomical characteristics, including body mass index (BMI), abdominal wall thickness, and gestational age. Amniocentesis needles with lengths ranging from 100 to 150 mm offer healthcare providers flexibility in accommodating differences in patient anatomy and optimizing needle insertion depth during the procedure.
Full Report: https://www.kbvresearch.com/amniocentesis-needle-market/
The North America region dominated the Global Amniocentesis Needle Market, by Region in 2022, and would continue to be a dominant market till 2030; thereby, achieving a market value of $95.7 million by 2030. The Europe region is anticipated to grow at a CAGR of 6.5% during (2023 - 2030). Additionally, The Asia Pacific region would witness a CAGR of 7.3% during (2023 - 2030).
By Procedure
By End-use
By Type
Unique Offerings 
